Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul-Henri Cottu

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|May 19, 2005
[Breast carcinoma and genomic technology: contribution of DNA microarrays]Nicolas Sévenet, Paul-Henri Cottu
Presse Medicale (Paris, France : 1983)|March 1, 2003
[Mass screening for breast cancer]Paul-Henri Cottu, Caroline Cuvier, Francine Perret, et al.
Breast Cancer Research and Treatment|November 2, 2005
A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patientsBruno Cutuli, Paul Henri Cottu, Jean Paul Guastalla, et al.
The Breast Journal|February 27, 2007
Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patientsThibaut Caruba, Paul-Henri Cottu, Isabelle Madelaine-Chambrin, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
[Initial pretherapeutic assessment of anal epidermoid carcinoma]Vincent de Parades, Pierre Bauer, Jean-Louis Benbunan, et al.
Bulletin Du Cancer|May 6, 2011
[Survival of breast cancers patients with meningeal carcinoma]Hélène Petithuguenin Gauthier, Marie-Noëlle Guilhaume, François-Clément Bidard, et al.
Plos One|November 9, 2017
Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort studyFrançoise Laroche, Serge Perrot, Terkia Medkour, et al.
The Journal of Pain|December 25, 2013
Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort studyFrancoise Laroche, Joël Coste, Terkia Medkour, et al.
Anticancer Research|March 19, 2017
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational StudyVeronique Dieras, Simona Pop, Frederique Berger, et al.
Bulletin Du Cancer|December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|May 19, 2005
[Breast carcinoma and genomic technology: contribution of DNA microarrays]Nicolas Sévenet, Paul-Henri Cottu
Presse Medicale (Paris, France : 1983)|March 1, 2003
[Mass screening for breast cancer]Paul-Henri Cottu, Caroline Cuvier, Francine Perret, et al.
Breast Cancer Research and Treatment|November 2, 2005
A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patientsBruno Cutuli, Paul Henri Cottu, Jean Paul Guastalla, et al.
The Breast Journal|February 27, 2007
Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patientsThibaut Caruba, Paul-Henri Cottu, Isabelle Madelaine-Chambrin, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
[Initial pretherapeutic assessment of anal epidermoid carcinoma]Vincent de Parades, Pierre Bauer, Jean-Louis Benbunan, et al.
Bulletin Du Cancer|May 6, 2011
[Survival of breast cancers patients with meningeal carcinoma]Hélène Petithuguenin Gauthier, Marie-Noëlle Guilhaume, François-Clément Bidard, et al.
Plos One|November 9, 2017
Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort studyFrançoise Laroche, Serge Perrot, Terkia Medkour, et al.
The Journal of Pain|December 25, 2013
Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort studyFrancoise Laroche, Joël Coste, Terkia Medkour, et al.
Anticancer Research|March 19, 2017
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational StudyVeronique Dieras, Simona Pop, Frederique Berger, et al.
Bulletin Du Cancer|December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.
Pageof 2